Page last updated: 2024-10-22

amlexanox and Atopic Hypersensitivity

amlexanox has been researched along with Atopic Hypersensitivity in 2 studies

amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.

Research Excerpts

ExcerptRelevanceReference
"Amlexanox has also been legally utilized and administered in Japan as a treatment for asthma, a chronic pulmonary disease characterized by inflammation of the lower respiratory tract."2.66Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease. ( Dosanjh, A; Won, CY, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dosanjh, A1
Won, CY1
Kohno, S1
Shimizu, T1
Mizuta, J1
Ogino, K1
Yamamura, H1
Ohata, K1
Kawai, M1
Shindo, T1
Wada, H1
Hitomi, S1

Reviews

1 review available for amlexanox and Atopic Hypersensitivity

ArticleYear
Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease.
    The Yale journal of biology and medicine, 2020, Volume: 93, Issue:5

    Topics: Aminopyridines; Animals; Anti-Allergic Agents; Asthma; Humans; Hypersensitivity, Immediate; Inflamma

2020

Other Studies

1 other study available for amlexanox and Atopic Hypersensitivity

ArticleYear
[Inhibitory effect of amlexanox (AA-673) on the immunological and non-immunological release of histamine or leukotrienes].
    Arerugi = [Allergy], 1989, Volume: 38, Issue:11

    Topics: Aminopyridines; Benzoquinones; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release;

1989